PDDI Info Model Task Force - Standard Sub-team minutes for 6/20

Hi Team,

Sorry for the delay....the minutes and link to meeting recording for the 
June 20th meeting of the *standard sub-team* of the PDDI Info Model Task 
Force are pasted below. Thanks to Elizabeth Garcia for writing them!

Kind regards, -R


    Minutes for 6/20/2016 (Standard subgroup)

In Attendance:  Mathias Brochhausen, Kim Nolen, Oya Beyan, Clément 
Goehrs, Michel Dumontier, Richard Boyce, Louisa Zhang, Elizabeth Garcia

Meeting recording: http://goo.gl/X4SVzG

Meeting:

  *

    Update on the PDDIs to focus on

      o

        Content team progress on drug-drug interactions

      o

        Spreadsheet: Suggested potential drug-drug interactions
        <https://docs.google.com/spreadsheets/d/1DIeIuo7tZ6nVvd6MdO2xzzLtOSPXjAHI-DdBe9M3kiw/edit#gid=716618333>

          +

            Includes drug pairs that are somewhat representative of the
            minimum information items

          +

            Highlighting:  Decision Tree has been developed that will
            guide the evidence and grading the interaction

              #

                Not computable, but it’s important because the minimum
                info model will be based off of this

              #

                Where it fits in with the task force’s goals:
                  information items based off of expert consensus from
                prior work

              #

                Demonstrating usefulness:  need specific interactions to
                focus on & important factors about those interactions

  *

    Progress on clinical consequence and evidence definitions(Elizabeth)

      o

        User-Centered Definitions
        <https://docs.google.com/document/d/1MGPXSkRZVXCd8nzhEgHJLLSxYLhcixiNPqnAmty---M/edit?usp=sharing>(allows
        for further comments)

      o

        We will be using these definitions to develop a new ontology for
        the minimum information model

      o

        All comments collected through Qualtrics surveys and prior work
        will be incorporated into appendices that will be part of the
        W3C document

      o

        Clinical Consequences:  no disagreement

      o

        Evidence

          +

            Discussion about scope (i.e., human vs. animal), does not
            address information important for CDS

              #

                Definition is broad enough to include elements like
                study design or annotation of evidence

          +

            Mathias will send out evidence work done so far (not to be
            shared outside of the task force)

  *

    Progress on user scenarios and use cases(Elizabeth)

      o

        Louisa and Elizabeth have created a list of information needs
        based on the user stories and stakeholder descriptions developed
        by the task force

          +

            Draft document: PDDI User Information Needs
            <https://docs.google.com/document/d/1EhHudBgH4TqNdqULZKJYp2tgyO2QtHANdbFSXH5rlUg/edit?usp=sharing>

          +

            Next steps are to synthesize the information needs into user
            stories

      o

        Medication Reconciliation Use Cases:  essential queries we’d
        want to the information model to support

          +

            Hospital pharmacist and consultant pharmacist

          +

            Draft medication reconciliation use cases will be added to
            PDDI site by July 1

      o

        Targeted and open-ended questions will be sent out to solicit
        feedback

  *

    Progress on setting the scope(Mathias)

      o

        Knowledge Representation Core Considerations
        <https://docs.google.com/document/d/14saXL4qhusPHxxN1Aymc5z_u7vH3j3V-YF9TKNjRxLQ/edit#heading=h.rrsinxzgxju8>

          +

            To what extent the knowledge representation should address
            issues relating to data integrity

          +

            New effort outside the core considerations to address these
            concerns

          +

            Useful discussion to have from the perspective of mode of
            representation

              #

                Not what we represent, but how we represent information

      o

        Next meeting:  July 7th, 9:00 AM – 10:00 AM CST

          +

            Goal:  to wrap up the core consideration document and get it
            to a point to share with the Content group

          +

            Standard sub-team members are welcome to attend

      o

        Goal is to get this into W3C document

      o

        Awaiting the first draft of the use cases

  *

    Future user-centered definitions

      o

        Frequency of adverse events (exposure vs. harm)

          +

            Complex; may take a few months to develop

      o

        Mechanism of Interaction

          +

            DINTO and DIDEO have done a lot of work addressing

  *

    Follow up for July

      o

        July 7thmeeting re: Knowledge Representation Core Considerations

      o

        User Stories and Medication Reconciliation Use Cases in progress

          +

            Medication Reconciliation Use Cases will be discussed at
            all-team meeting

      o

        Decision Trees (Content group will be developing)

      o

        Close to submitting manuscript – systematic search for
        literature discussing information needs

      o Writing:  by the end of July, we should have the beginnings of a
        W3C note taking shape

Received on Friday, 24 June 2016 19:59:12 UTC